Coconut Creek, FL
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)Ataxia Telangiectasia Children's Project Inc, founded in 1993, is a community nonprofit in the Science & Technology sector that reported $1.8M in total revenue in fiscal year 2024. Revenue fell 28% from the prior year — a significant decline worth monitoring. Expenses of $2.2M exceeded revenue, resulting in a 23% operating deficit.
Ataxia-telangiectasia (A-T) is a genetic disease that causes loss of muscle control and balance, cancer, lung disease, and immune system problems in children and young adults, shortening their lives. The nonprofit A-T Children's Project partners with academic and industry investigators worldwide - organizing and supporting innovative research, conferences, clinical team, data platforms, and biomarker development - to optimize disease management strategies, develop new treatments, and find a cure.
Research and Clinical GrantsThe A-T Children's Project provides competitive awards for scientific and clinical research grants related to finding life-improving therapies and a cure for...
Research and Clinical GrantsThe A-T Children's Project provides competitive awards for scientific and clinical research grants related to finding life-improving therapies and a cure for ataxia-telangiectasia. Scientific excellence and relevance to A-T are the paramount criteria used to select research projects. Grant award decisions are made through a careful and detailed, two-tiered peer-review selection process. Consistent with the urgency felt by all families impacted by this disease, the A-T Children's Project's current focus is on funding innovative research strategies that look at A-T in new ways and that include a clear 'yes or 'no' answer to the hypothesis rather than merely defining a mechanism. Highest priority is given to projects that, while drawing on basic discoveries, include creative strategies for suggesting and evaluating specific disease-modifying and symptomatic interventions.
Conferences and Research SupportThe A-T Children's Project holds scientific meetings and workshops regularly as a way to encourage more cooperation between A-T research teams, to reduce redundancy in...
Conferences and Research SupportThe A-T Children's Project holds scientific meetings and workshops regularly as a way to encourage more cooperation between A-T research teams, to reduce redundancy in their work, and to bring scientists from different fields together to generate new research strategies. The agendas always include presentations of unpublished data and open discussions and debate. The Organization also sponsors scientific conferences whose mission falls within this realm. The Organization has found that these scientific meetings, properly orchestrated generate new research strategies, help to form new collaborations between previously competing labs, and encourage sharing of limited patient tissue samples and animal models of A-T between labs. They consistently help to accelerate research progress. Additionally, staff of the A-T Children's Project coordinate the Global A-T Family Data Platform, a patient-driven effort overseen by A-T families and experts worldwide through which health information, genetic, and potentially other types of data about people with A-T can be shared with researchers, enabling them to access important patient data from around the world quickly, securely, and efficiently, hopefully leading to new discoveries.
Awareness and EducationThe A-T Children's Project maintains a database of people interested in receiving news and other information from the A-T Children's Project including families, extended family...
Awareness and EducationThe A-T Children's Project maintains a database of people interested in receiving news and other information from the A-T Children's Project including families, extended family members, friends, caregivers, therapists, doctors, donors, volunteers, nonprofit organizations, and others interested in learning about A-T and our progress. The Organization does not charge membership fees or other fees for educational and awareness materials. Additional awareness activities include: making sure event attendees know what A-T is and the importance of the work they are supporting; conducting outreach to assist with the timely and accurate diagnosis of A-T; creating materials to help explain A-T and the Organization's research progress; answering questions and providing materials to constituents and the general public about A-T; and, maintaining a website with up-to-date information about the disease and the Organization's research projects.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $1,808,873 | $2,502,362 | -0.3% |
| Expenses | $2,217,433 | $1,895,973 | +0.2% |
| Net Income | $-408,560 | $606,389 | -1.7% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Bradley A Margus | President | 20.00 |
Officer
Director
|
$0 | $0 | $0 |
| Amy Madison | Vice President | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| Gregory Jehlik | Secretary | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| Timothy Rahall | Treasurer | 3.00 |
Officer
Director
|
$0 | $0 | $0 |
| Jennifer Thornton | Executive Director/Director | 50.00 |
Director
|
$220,950 | $20,805 | $241,755 |
| John Feeley | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Elizabeth Hughes | Director | 2.00 |
Director
|
$0 | $0 | $0 |
| Robert Middlebrook | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| David Veldink | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Douglas Weckstein | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $1,808,873 | $2,217,433 | $3,075,666 | $-408,560 |
| 2024 | $2,502,362 | $1,895,973 | $2,802,981 | $606,389 |
| 2023 | $1,567,615 | $1,481,299 | $2,125,334 | $86,316 |
| 2022 | $1,739,187 | $1,713,346 | $2,011,038 | $25,841 |
| 2021 | $1,461,138 | $1,326,098 | $1,453,834 | $135,040 |
Compare Ataxia Telangiectasia Children's Project Inc with other nonprofits in Florida and across the country.